drugset / Trial / NCT00489476
Staccato Loxapine in Migraine (in Clinic)
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The objective of this trial is to assess the efficacy and safety of Staccato Loxapine in patients with migraine headache with or without aura in a clinical setting.
Timeline
- Start
- 2007-06
- Primary completion
- 2007-12
- Completion
- 2007-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | loxapine | Small molecule | 1.25 mg | Inhaled |
| Subject | loxapine | Small molecule | 2.5 mg | Inhaled |
| Subject | loxapine | Small molecule | 5 mg | Inhaled |